The Effects of Repeated Operational Stress and Limited Recovery on Resilience Capacity

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age17-39
SponsorUnited States Army Research Institute of Environmental Medicine

About this trial

This longitudinal study will examine the effects of repeated bouts of operational stress and limited recovery on integrated MPS, whole-body protein balance, iron absorption, and aerobic performance. Following baseline characterization measures, active adults (n=24) representative of normal weight phenotype (NW; n=12) and overweight phenotype (OW; n=12) will complete a 48h balance phase preceding two rounds of repeated 72h energy deficit exposure each immediately followed by a 48h recovery phase. NW cutoff will be defined ≤ 22% body fat for males and ≤ 32% body fat for females. OW cutoff will be defined as \>22% body fat for males and \>32% body fat for females. These body composition cutoffs are informed by the maximum allowable percent body fat standards outlined in current Army Regulation 600-9. Additional details for determining % body fat are outlined in the experimental procedures section of the protocol.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Men and women aged 18 - 39 years (17 - 39 years if military personnel)

Weight stable in the past 2 months (± approximately 5 kg)

Healthy without evidence of chronic illness or musculoskeletal injury as determined by the USARIEM Office of Medical Support and Oversight (OMSO) or home duty station medical support (HMS)

Functional exercise (i.e., step ups, box jumps, body mass movements) and/or aerobic exercise trained defined by self-report as performing ≥ 2 sessions/wk for previous 6 months

Disqualifiers

Musculoskeletal injuries that compromise exercise capability as determined by OMSO or HMS

Metabolic or cardiovascular abnormalities, sleep disorders (i.e., sleep apnea) gastrointestinal disorders (e.g., kidney disease, diabetes, cardiovascular disease, etc.) as determined by OMSO or HMS

Abnormal or problems with blood clotting as determined by OMSO or HMS

History of complications with lidocaine or similar local anesthetic analogue

Trial design

Design model

Parallel

Treatments tested in this trial

  • Operational Stressors

    Other intervention

    Intervention consists of a 48 hour energy balance phase preceding two rounds of repeated 72 hour energy deficit exposure each immediately followed by a 48h recovery phase. Balance and recovery phases will meet 100% of baseline energy requirements. Energy deficit phases will include an approximate 60% energy deficit of total daily energy requirements achieved through both a reduction in dietary intake and increased energy expenditure through physical activity.

Treatment groups

24 Participants
are divided into 2 treatment groups
Group A: Active adults representative of overweight phenotypeExperimental treatment 1 intervention
Group B: Active adults representative of normal weight phenotypeActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Integrated muscle protein synthesis

deuterium oxide stable isotope

Time frame
Days 1-13
2

Whole-body protein balance

15N alanine stable isotope

Time frame
24 hours
3

Iron Absorption

57-Fe dissolved in water

Time frame
24 hours

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: